30 junho 2020
CanSino's COVID-19 vaccine candidate approved for military use in China: China’s military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics (6185.HK) after clinical trials proved it was safe and showed some efficacy
The Ad5-nCoV is one of China’s eight vaccine candidates approved for human trials at home and abroad for the respiratory disease caused by the new coronavirus. The shot also won approval for human testing in Canada.
The Ad5-nCoV is one of China’s eight vaccine candidates approved for human trials at home and abroad for the respiratory disease caused by the new coronavirus. The shot also won approval for human testing in Canada.
WHO Chief On COVID-19 Pandemic: 'The Worst Is Yet To Come': Tedros Adhanom Ghebreyesus said: "We all want this to be over. We all want to get on with our lives. But the hard reality is this is not even close to being over."
"Although many countries have made some progress, globally the pandemic is actually speeding up," he said.
He said the solution is the same as it has been since the early days of the pandemic: "Test, trace, isolate and quarantine."
"Although many countries have made some progress, globally the pandemic is actually speeding up," he said.
He said the solution is the same as it has been since the early days of the pandemic: "Test, trace, isolate and quarantine."
WHO sending team to China to investigate origins of coronavirus: The United States, the WHO’s largest critic which has said it is leaving the U.N. agency, has called for an investigation into the origin of the coronavirus.
President Donald Trump and Secretary of State Mike Pompeo have said it may have originated in a laboratory, although they have presented no evidence for this and China strongly denies it.
President Donald Trump and Secretary of State Mike Pompeo have said it may have originated in a laboratory, although they have presented no evidence for this and China strongly denies it.
Mutating coronavirus: what it means for all of us: Of course, disease outcomes are affected by other factors, too, such as how old or sick the host is. The effect of interventions also has to be considered. Until a large dataset of genome data from mild or non-symptomatic patients from a diverse population is available, it will be difficult to deduce how the convergent mutations identified translate to severity of disease.
Viewpoint: It’s better to admit ‘I don’t know’ than to speculate during a pandemic: COVID-19 has elevated, but also exposed scientists. Politicians want clarity, but it’s crucial to explain what is known, unknown and unknowable
How remdesivir works, and why it's not the ultimate coronavirus killer: The antiviral drug remdesivir has been approved for emergency use among hospitalized COVID-19 patients, and in recent studies, has shown promise as a treatment for the pandemic disease.
How exactly does remdesivir counter SARS-CoV-2 -- the coronavirus strain responsible for COVID-19?
How exactly does remdesivir counter SARS-CoV-2 -- the coronavirus strain responsible for COVID-19?
Subscrever:
Comentários (Atom)
-
The dangers of Covid-19 far outweigh the risks of a vaccine : So can I tell you that there won't be a long-term unknown side effect to t...
-
The Value of a Cure: An Asset Pricing Perspective : We provide an estimate of the value of a cure using the joint behavior of stock prices ...
-
A flood of coronavirus apps are tracking us. Now it’s time to keep track of them. So far we have documented 25 individual, significant auto...